8-K: Cardinal Health Extends Receivables Facility to 2028

Cardinal Health Funding, LLC and its subsidiaries extended their receivables purchase agreement with several financial institutions, pushing the facility's termination date to September 28, 2028.

Summary

• Cardinal Health Funding, LLC and Cardinal Health 23 Funding, LLC, subsidiaries of Cardinal Health, Inc., entered into a First Amendment to their Fifth Amended and Restated Receivables Purchase Agreement.
• The amendment, dated September 30, 2025, extends the term of the receivables financing facility.
• The new Scheduled Facility Termination Date for the facility is September 28, 2028, extended from the previous date of September 30, 2025.
• Key financial institutions involved include Wells Fargo Bank, N.A., Liberty Street Funding LLC, The Bank of Nova Scotia, PNC Bank, National Association, Bank of America, National Association, Victory Receivables Corporation, and MUFG Bank, LTD.
• These financial institutions also provide various commercial banking, investment banking, and other financial advisory services to Cardinal Health, Inc. and its affiliates.

Sentiment

Score: 7

Explanation: The extension of a significant receivables financing facility is a positive indicator of continued financial stability and access to liquidity, reflecting confidence from a syndicate of major financial institutions. It ensures ongoing operational funding without introducing new liabilities or significant changes.

Positives

• Secured continued access to a significant receivables financing facility, enhancing liquidity and working capital management.
• The extension of the facility term to September 28, 2028, provides long-term financial stability and predictability for the company's funding structure.

Risks

• Dependence on financial institutions for liquidity, with potential for increased costs or reduced availability in adverse market conditions.
• Risk of Amortization Events if certain financial covenants or performance metrics (e.g., Delinquency Ratio, Collections-to-Sales Ratio, Dilution-to-Sales Ratio) are not met, which could trigger early termination or remedies by the Agent.
• Potential for increased costs if a 'Regulatory Change' or 'Specified Regulation' impacts funding sources, leading to higher fees or reduced returns for affected parties.
• Exposure to 'Defaulting Financial Institutions' within the syndicate, which could impact funding availability or require cash collateralization.
• Operational risks related to the servicing and collection of receivables, including compliance with the Credit and Collection Policy and potential for commingling of funds.

Future Outlook

The extension of the receivables purchase agreement to September 28, 2028, indicates a stable outlook for the company's working capital management and liquidity through this facility, providing long-term financial flexibility.

Management Comments

• No notable direct quotes from management were provided in this filing.

Industry Context

Receivables financing facilities are a common tool for large distributors like Cardinal Health to optimize working capital and enhance liquidity by monetizing accounts receivable. This extension aligns with typical industry practices for maintaining robust financial flexibility and managing cash flow efficiently.

Comparison to Industry Standards

• NA

Related Party Transactions

• Cardinal Health Funding, LLC and Cardinal Health 23 Funding, LLC, as sellers, are receivables financing subsidiaries of Griffin Capital, LLC and Cardinal Health 23, LLC, respectively, which are indirect subsidiaries of Cardinal Health, Inc.
• Griffin Capital, LLC acts as the original servicer, and Cardinal Health 23, LLC acts as the servicer for the receivables, both being indirect subsidiaries of Cardinal Health, Inc.
• The financial institutions involved in the facility (Wells Fargo, Bank of America, MUFG, Bank of Nova Scotia, PNC) also perform various commercial banking, investment banking, and other financial advisory services for Cardinal Health, Inc. and its affiliates, including acting as dealers for commercial paper and members of the revolving credit facility syndicate.

Stakeholder Impact

• Shareholders: Positive impact due to the assurance of continued liquidity and stable financing, supporting ongoing business operations and financial health.
• Creditors: Positive impact as the extension of the receivables facility reinforces the company's ability to manage its working capital and meet its financial obligations.
• Employees, Customers, and Suppliers: Indirectly positive impact as stable financing supports the company's operational continuity, ability to pay suppliers, and serve customers effectively.

Next Steps

• Continued operation of the receivables financing facility under the amended terms until September 28, 2028.
• Ongoing compliance with all covenants and reporting requirements outlined in the amended Receivables Purchase Agreement by Cardinal Health and its subsidiaries.

Key Dates

Recommendation

The extension of the receivables financing facility is a standard operational update that ensures continued liquidity and working capital management. It does not introduce new material financial performance data or strategic shifts that would warrant a change in investment recommendation. It confirms ongoing financial stability but does not present a catalyst for significant upside or downside.

Keywords

Cardinal Health, receivables financing, credit facility, liquidity, working capital, debt extension, financial institutions, asset-backed commercial paper, SEC filing, 8-K